Moreover, we revealed that BMT caused less DNA damage in donor cells when STING-deficient HSPCs were used as donor cells in CML-bearing mice, compared with the use of WT HSPCs. Here, STING1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.